Drugs Made In America Acquisition II Corp. (DMIIR) Stock Ticker
DMIIR right now
Market factors today
Unlock the full DMIIR picture
About Drugs Made In America Acquisition II Corp.
Drugs Made In America Acquisition II Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on August 23, 2024 and is headquartered in Fort Lauderdale, FL.
DMIIR stock facts
| Ticker symbol | DMIIR |
| Exchange | NASDAQ |
| Sector | Financial Services |
| Industry | Financial - Conglomerates |
| Market cap | $4.2M |
| CEO | Roger Bendelac |
| Employees | 2 |
| Headquarters | New York, NY, US |
| IPO date | 2025-12-04 |
| Website | dmaacorp.com |
What you can see for DMIIR on Tickr
Live DMIIR price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the DMIIR report.
Rankings
FAQ
What is the ticker symbol for Drugs Made In America Acquisition II Corp.?
The ticker symbol for Drugs Made In America Acquisition II Corp. is DMIIR, listed on the NASDAQ.
What is DMIIR?
Drugs Made In America Acquisition II Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on August 23, 2024 and is headquartered in Fort Lauderdale, FL.